Joseph R. Bertino, Scientist and Clinical Oncologist. J Clin Oncol. 2022 05 10; 40(14):1511-1513.
View in:
PubMed
Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma. N Engl J Med. 2018 04 19; 378(16):1560.
View in:
PubMed
Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni Bonadonna. Tumori. 2016 Mar-Apr; 102(2):124-6.
View in:
PubMed
Gianni Bonadonna (1934-2015). Leuk Lymphoma. 2016; 57(4):739.
View in:
PubMed
Gianni Bonadonna: A Personal Remembrance. Oncologist. 2015 Nov; 20(11):1348-9.
View in:
PubMed
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
View in:
PubMed
Advanced DLBCL: as systemic therapy improves, the need for RT diminishes. Oncology (Williston Park). 2014 Dec; 28(12):1085-6.
View in:
PubMed
Treatment of Hodgkin lymphoma: a 50-year perspective. J Clin Oncol. 2014 Jan 20; 32(3):163-8.
View in:
PubMed
Treatment for favorable localized Hodgkin lymphoma: the final answer is awaited. Oncology (Williston Park). 2012 Dec; 26(12):1199-200, 1202.
View in:
PubMed
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone? Leuk Lymphoma. 2012 Nov; 53(11):2143-50.
View in:
PubMed
Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful? J Clin Oncol. 2012 Jun 20; 30(18):2171-2.
View in:
PubMed
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2012 May; 97(5):758-65.
View in:
PubMed
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy? Curr Hematol Malig Rep. 2011 Sep; 6(3):180-6.
View in:
PubMed
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood. 2011 May 19; 117(20):5314-20.
View in:
PubMed
Hematology in 2010: New therapies and standard of care in oncology. Nat Rev Clin Oncol. 2011 Feb; 8(2):67-8.
View in:
PubMed
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma. Ann Oncol. 2011 Apr; 22(4):910-915.
View in:
PubMed
Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. J Clin Oncol. 2010 Mar 20; 28(9):1611-5.
View in:
PubMed
Is chemotherapy alone for early Hodgkin lymphoma an emerging therapeutic option? Oncologist. 2009 Dec; 14(12):1167-8.
View in:
PubMed
Long-term follow-up of survival in Hodgkin's lymphoma. N Engl J Med. 2009 Dec 10; 361(24):2390-1.
View in:
PubMed
What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma? J Clin Oncol. 2010 Jan 01; 28(1):e8.
View in:
PubMed
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. J Clin Oncol. 2009 Dec 20; 27(36):6101-8.
View in:
PubMed
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma. 2009 Oct; 50(10):1606-17.
View in:
PubMed
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning. J Clin Oncol. 2008 Dec 10; 26(35):5767-74.
View in:
PubMed
What constitutes "improved prognosis"? J Clin Oncol. 2008 Apr 20; 26(12):1913-4.
View in:
PubMed
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. Biol Blood Marrow Transplant. 2008 Apr; 14(4):418-25.
View in:
PubMed
Relapsed and refractory Hodgkin's lymphoma: new avenues? Hematol Oncol Clin North Am. 2007 Oct; 21(5):929-41.
View in:
PubMed
Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206. Leuk Lymphoma. 2007 Jul; 48(7):1313-9.
View in:
PubMed
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351. Leuk Lymphoma. 2007 May; 48(5):870-80.
View in:
PubMed
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol. 2007 Jun; 18(6):1071-9.
View in:
PubMed
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901. Leuk Lymphoma. 2007 Jan; 48(1):97-103.
View in:
PubMed
Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leuk Lymphoma. 2006 Aug; 47(8):1511-7.
View in:
PubMed
The cancer and leukemia group B lymphoma committee. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 2):3572s-5s.
View in:
PubMed
Where does hematology end and oncology begin? Questions of professional boundaries and medical authority. J Clin Oncol. 2006 Jun 01; 24(16):2583-8.
View in:
PubMed
Introduction to a special series of unique entities within the spectrum of large-cell lymphoma. Oncologist. 2006 Apr; 11(4):374.
View in:
PubMed
Clinical trials in North America. Eur J Haematol Suppl. 2005 Jul; (66):121-4.
View in:
PubMed
Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103. J Clin Oncol. 2005 Jun; 23(16_suppl):6530.
View in:
PubMed
Chemotherapy alone for early Hodgkin's lymphoma: an emerging option. J Clin Oncol. 2005 Jul 20; 23(21):4574-6.
View in:
PubMed
Lymphoma: present and future challenges. Semin Hematol. 2004 Oct; 41(4 Suppl 7):26-31.
View in:
PubMed
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? J Clin Oncol. 2004 Apr 15; 22(8):1532-3.
View in:
PubMed
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer. 2004 Apr 01; 100(7):1438-48.
View in:
PubMed
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Leuk Lymphoma. 2004 Jan; 45(1):85-92.
View in:
PubMed
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity. Cancer. 2003 Sep 01; 98(5):978-82.
View in:
PubMed
Prognostic factors in large-cell lymphoma. Clin Adv Hematol Oncol. 2003 May; 1(5):269-70.
View in:
PubMed
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003 Feb 15; 21(4):607-14.
View in:
PubMed
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. Ann Oncol. 2003 Feb; 14(2):268-72.
View in:
PubMed
Long-term follow-up of Hodgkin's disease trial. N Engl J Med. 2002 May 02; 346(18):1417-8.
View in:
PubMed
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002 Apr 15; 20(8):2101-8.
View in:
PubMed
New treatments for advanced Hodgkin's disease: an uphill fight beginning close to the top. J Clin Oncol. 2002 Feb 01; 20(3):607-9.
View in:
PubMed
Lymphomas of the breast: primary and secondary involvement. Cancer. 2002 Jan 01; 94(1):6-13.
View in:
PubMed
Primary treatment of Hodgkin's disease. Ann Oncol. 2002; 13 Suppl 4:153-8.
View in:
PubMed
Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer. Cancer Invest. 2002; 20(5-6):686-92.
View in:
PubMed
Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease. Ann Oncol. 2002; 13 Suppl 1:112-6.
View in:
PubMed
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Cancer. 2001 Jul 15; 92(2):207-17.
View in:
PubMed
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning. Health Psychol. 2001 Jan; 20(1):71-5.
View in:
PubMed
Burnout: caring for the caregivers. Oncologist. 2000; 5(5):425-34.
View in:
PubMed
A new addition to the Journal of Clinical Oncology: the art of oncology--when the tumor is not the target. J Clin Oncol. 2000 Jan; 18(1):3.
View in:
PubMed
Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051). Cancer. 1999 Oct 15; 86(8):1590-5.
View in:
PubMed
The lymphomas. Semin Hematol. 1999 Oct; 36(4 Suppl 7):84-94.
View in:
PubMed
Clinical research saves money: reflections on high-dose therapy of breast cancer. J Clin Oncol. 1999 Jul; 17(7):1965-6.
View in:
PubMed
Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B study. Am J Clin Oncol. 1999 Jun; 22(3):218-22.
View in:
PubMed
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999 Apr; 17(4):1244.
View in:
PubMed
Mediastinal large cell lymphoma: prognostic significance of CT findings at presentation and after treatment. Oncology. 1998 Jul-Aug; 55(4):284-8.
View in:
PubMed
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol. 1998 Mar; 9(3):297-306.
View in:
PubMed
Treatment of relapsed Hodgkin's disease: strategies and prognostic factors. Ann Oncol. 1998; 9 Suppl 5:S91-6.
View in:
PubMed
Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe? J Clin Oncol. 1997 Oct; 15(10):3169-70.
View in:
PubMed
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement. Int J Radiat Oncol Biol Phys. 1997 Sep 01; 39(2):361-9.
View in:
PubMed
Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol. 1997 Sep; 15(9):3060-6.
View in:
PubMed
CHOP may have been part of the beginning but certainly not the end: issues in risk-related therapy of large-cell lymphoma. J Clin Oncol. 1997 May; 15(5):1713-6.
View in:
PubMed
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol. 1997 Apr; 15(4):1631-7.
View in:
PubMed
Is CHOP the standard of therapy for poor-prognosis large-cell lymphoma? Ann Oncol. 1997; 8 Suppl 1:61-2.
View in:
PubMed
Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation. AJR Am J Roentgenol. 1996 Aug; 167(2):425-30.
View in:
PubMed
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD? Leukemia. 1996 Jun; 10 Suppl 2:s68.
View in:
PubMed
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996 May 01; 87(9):3625-32.
View in:
PubMed
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol. 1996 May; 14(5):1589-98.
View in:
PubMed
Current strategies for early Hodgkin's disease. Ann Oncol. 1996; 7 Suppl 4:91-3.
View in:
PubMed
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. J Clin Oncol. 1995 Dec; 13(12):2916-23.
View in:
PubMed
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. J Clin Oncol. 1995 Aug; 13(8):2005-11.
View in:
PubMed
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995 May-Jun; 1(1):33-42.
View in:
PubMed
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial. J Clin Oncol. 1995 Apr; 13(4):947-52.
View in:
PubMed
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. J Clin Oncol. 1994 Dec; 12(12):2567-72.
View in:
PubMed
ASCO 30 years later: the state of the Society. J Clin Oncol. 1994 Nov; 12(11):2510-3.
View in:
PubMed
The cellular biology of the Reed-Sternberg cell. Blood. 1994 Aug 15; 84(4):1005-19.
View in:
PubMed
Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan. Am J Hematol. 1994 Apr; 45(4):283-7.
View in:
PubMed
Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B. Psychother Psychosom. 1994; 62(3-4):193-9.
View in:
PubMed
High-dose therapy: here to stay or just visiting? J Clin Oncol. 1994 Jan; 12(1):5-6.
View in:
PubMed
Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma. Ann Oncol. 1994; 5 Suppl 2:121-2.
View in:
PubMed
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. J Clin Oncol. 1993 Nov; 11(11):2081-9.
View in:
PubMed
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993 Jul; 11(7):1336-43.
View in:
PubMed
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer. 1993 Jul 01; 72(1):207-12.
View in:
PubMed
Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine. Am J Hematol. 1993 Jun; 43(2):95-102.
View in:
PubMed
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes. J Natl Cancer Inst. 1993 May 19; 85(10):812-7.
View in:
PubMed
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol. 1993 May; 11(5):937-42.
View in:
PubMed
Prognostic factors for patients with Hodgkin disease in first relapse. Cancer. 1993 Apr 15; 71(8):2613-20.
View in:
PubMed
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993 Apr 15; 71(8):2585-97.
View in:
PubMed
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B. Cancer. 1993 Mar 01; 71(5):1857-66.
View in:
PubMed
Myelosuppression and "conventional" chemotherapy: what price, what benefit? J Clin Oncol. 1993 Jan; 11(1):1-2.
View in:
PubMed
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study. J Clin Oncol. 1993 Jan; 11(1):155-60.
View in:
PubMed
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992 Nov 19; 327(21):1478-84.
View in:
PubMed
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. Cancer. 1992 Nov 15; 70(10):2508-16.
View in:
PubMed
Current therapeutic strategies in Hodgkin's disease. Ann Oncol. 1992 Sep; 3 Suppl 4:67-8.
View in:
PubMed
The second chance for advanced Hodgkin's disease. J Clin Oncol. 1992 Feb; 10(2):175-7.
View in:
PubMed
Long-term followup of 150 patients with testicular cancer treated at a single institution. J Urol. 1992 Jan; 147(1):82-8.
View in:
PubMed
Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Clin Oncol. 1991 Oct; 9(10):1916-20.
View in:
PubMed
Small non-cleaved cell lymphoma in adults. Am J Hematol. 1991 Sep; 38(1):40-7.
View in:
PubMed
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens. Cancer. 1991 Aug 15; 68(4):699-705.
View in:
PubMed
Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol. 1991 Jul; 9(7):1196-203.
View in:
PubMed
Hodgkin's disease: controversies and challenges for the future. Haematologica. 1991 Jul-Aug; 76(4):263-79.
View in:
PubMed
Has the MOPP era ended? Br J Cancer. 1991 Apr; 63(4):483.
View in:
PubMed
Report of the first workshop on prognostic factors in large-cell lymphomas. Ann Oncol. 1991 Feb; 2 Suppl 2:213-7.
View in:
PubMed
Will doxorubicin-containing regimens replace MOPP and its variants? Leukemia. 1991; 5 Suppl 1:50-2.
View in:
PubMed
Is there an effective salvage therapy for advanced Hodgkin's disease? Ann Oncol. 1991 Jan; 2 Suppl 1:1-7.
View in:
PubMed
Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol. 1990 Dec; 8(12):1966-70.
View in:
PubMed
Who should pay for clinical research? J Clin Oncol. 1990 Nov; 8(11):1775-6.
View in:
PubMed
Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 1990 May 01; 65(9 Suppl):2132-47.
View in:
PubMed
Clinical characteristics of the blast phase of chronic granulocytic leukemia. Hematol Oncol Clin North Am. 1990 Apr; 4(2):359-67.
View in:
PubMed
Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Semin Oncol. 1990 Feb; 17(1 Suppl 2):2-6.
View in:
PubMed
Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol. 1990 Feb; 8(2):257-65.
View in:
PubMed
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. J Clin Oncol. 1990 Jan; 8(1):84-93.
View in:
PubMed
High-dose cytosine arabinoside in relapsed and refractory non-Hodgkin's lymphoma. Limited role as a single agent. Cancer. 1989 Nov 15; 64(10):2014-8.
View in:
PubMed
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989 Nov; 7(11):1630-6.
View in:
PubMed
Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood. 1989 Nov 01; 74(6):2203-11.
View in:
PubMed
Recent issues in chemotherapy for Hodgkin's disease. Curr Opin Oncol. 1989 Oct; 1(1):29-31.
View in:
PubMed
Stage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol. 1989 Aug; 7(8):1059-65.
View in:
PubMed
Predictive factors for long-term survival in patients with advanced ovarian cancer. Gynecol Oncol. 1989 Jul; 34(1):88-93.
View in:
PubMed
Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. J Clin Oncol. 1989 May; 7(5):613-8.
View in:
PubMed
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease. Cancer. 1989 Mar 15; 63(6):1060-4.
View in:
PubMed
Treatment of chronic granulocytic leukemia in blastic crisis. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:131-2.
View in:
PubMed
The role of alkylating agents in acute and chronic leukemia. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:46-7.
View in:
PubMed
Treatment of the blastic phase of chronic myelogenous leukemia with high-dose cytosine arabinoside. Am J Clin Oncol. 1988 Dec; 11(6):623-6.
View in:
PubMed
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol. 1988 Oct; 6(10):1576-83.
View in:
PubMed
The dose dilemma. J Clin Oncol. 1988 Sep; 6(9):1363-4.
View in:
PubMed
Surgical therapy of localized abdominal non-Hodgkin's lymphomas. Surgery. 1988 Jun; 103(6):609-14.
View in:
PubMed
Residual mass in lymphoma may not be residual disease. J Clin Oncol. 1988 Jun; 6(6):931-3.
View in:
PubMed
Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease. Semin Hematol. 1988 Apr; 25(2 Suppl 2):58-65.
View in:
PubMed
Systemic therapy of breast cancer. Med J Aust. 1988 Jan 18; 148(2):88-91.
View in:
PubMed
Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med. 1987 Jun 11; 316(24):1499-505.
View in:
PubMed
The case for high-dose chemotherapy: is it chemotherapy's last gamble? Eur J Cancer Clin Oncol. 1987 Apr; 23(4):351-5.
View in:
PubMed
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. Semin Hematol. 1987 Apr; 24(2 Suppl 1):2-7.
View in:
PubMed
Experimental approaches in the treatment of lymphoma. Baillieres Clin Haematol. 1987 Mar; 1(1):205-21.
View in:
PubMed
New agents and new medical treatments for advanced breast cancer. Semin Oncol. 1987 Mar; 14(1):34-64.
View in:
PubMed
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood. 1987 Feb; 69(2):597-604.
View in:
PubMed
Splenic enlargement and hyperfunction as indications for splenectomy in chronic leukemia. Ann Surg. 1987 Jan; 205(1):13-7.
View in:
PubMed
Methotrexate-leucovorin factor rescue regimens in diffuse large cell lymphoma. NCI Monogr. 1987; (5):71-6.
View in:
PubMed
Monoclonal antibodies: their use in bone marrow transplantation. Prog Hematol. 1987; 15:137-81.
View in:
PubMed
Phase II trial of m-AMSA therapy in refractory Hodgkin's disease and non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 7972. Cancer Treat Rep. 1986 Oct; 70(10):1233-4.
View in:
PubMed
Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphoma. Am J Clin Oncol. 1986 Oct; 9(5):420-3.
View in:
PubMed
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med. 1986 Jun; 104(6):757-65.
View in:
PubMed
Hormonal agents and treatment of cancer. Urology. 1986 Jan; 27(1 Suppl):4-8.
View in:
PubMed
Duration of therapy in adjuvant chemotherapy trials. NCI Monogr. 1986; (1):95-8.
View in:
PubMed
Role of 99mTc methylene diphosphonate bone imaging in the management of lymphoma. Cancer Treat Rep. 1985 Dec; 69(12):1347-51.
View in:
PubMed
Interferon in the treatment of malignant lymphoma. Semin Oncol. 1985 Dec; 12(4 Suppl 5):25-9.
View in:
PubMed
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood. 1985 Dec; 66(6):1352-7.
View in:
PubMed
Bone marrow transplantation as salvage therapy in advanced Hodgkin's disease: allogeneic or autologous. J Clin Oncol. 1985 Nov; 3(11):1451-4.
View in:
PubMed
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol. 1985 Oct; 3(10):1301-8.
View in:
PubMed
Chronic granulocytic leukemia: the heterogeneity of stem cell differentiation within a single disease entity. Semin Oncol. 1985 Sep; 12(3):281-8.
View in:
PubMed
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone. J Clin Oncol. 1985 Sep; 3(9):1166-73.
View in:
PubMed
Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171. Cancer Treat Rep. 1985 Jun; 69(6):719-20.
View in:
PubMed
The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol. 1985 May; 3(5):637-40.
View in:
PubMed
Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol. 1985 Apr; 3(4):490-4.
View in:
PubMed
Reduction of fatal complications from combined modality therapy in Hodgkin's disease. J Clin Oncol. 1985 Apr; 3(4):501-5.
View in:
PubMed
Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cells. Am J Hematol. 1985 Mar; 18(3):243-9.
View in:
PubMed
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies. Cancer Treat Rep. 1984 Nov; 68(11):1343-50.
View in:
PubMed
High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma. Am J Med. 1984 Nov; 77(5):845-50.
View in:
PubMed
Phase II trial of etoposide in previously treated small cell carcinoma of the lung. Cancer Treat Rep. 1984 Nov; 68(11):1413-4.
View in:
PubMed
Therapy-related leukemia: a necessary complication of successful systemic chemotherapy? J Clin Oncol. 1984 Oct; 2(10):1077-9.
View in:
PubMed
Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature. Eur J Cancer Clin Oncol. 1984 Oct; 20(10):1233-8.
View in:
PubMed
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25; 2(8400):427-31.
View in:
PubMed
The treatment of locally advanced breast cancer. J Clin Oncol. 1984 Mar; 2(3):149-51.
View in:
PubMed
Chemotherapy of refractory germ cell cancer with Etoposide. J Clin Oncol. 1983 Nov; 1(11):706-9.
View in:
PubMed
Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA. 1983 Oct 07; 250(13):1733-41.
View in:
PubMed
Autologous bone-marrow transplantation: host effects of high-dose BCNU. J Clin Oncol. 1983 Oct; 1(10):610-20.
View in:
PubMed
Computed tomography of the abdomen and pelvis in non-Hodgkin lymphoma. J Comput Assist Tomogr. 1983 Oct; 7(5):846-50.
View in:
PubMed
Clinical value of ultrasonography for the management of non-Hodgkin lymphoma patients as compared with abdominal computed tomography. J Comput Assist Tomogr. 1983 Aug; 7(4):666-9.
View in:
PubMed
Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. J Clin Invest. 1983 Aug; 72(2):694-706.
View in:
PubMed
High-dose gallium imaging in lymphoma. Am J Med. 1983 Aug; 75(2):327-31.
View in:
PubMed
Phase I trial of mitoxantrone by 24-hour continuous infusion. Cancer Treat Rep. 1983 May; 67(5):435-8.
View in:
PubMed
T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood. 1983 Apr; 61(4):640-4.
View in:
PubMed
Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med. 1983 Apr; 74(4):557-63.
View in:
PubMed
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol. 1983 Feb; 1(2):91-8.
View in:
PubMed
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study. Cancer. 1983 Feb 01; 51(3):396-401.
View in:
PubMed
Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 1983 Jan; 61(1):85-91.
View in:
PubMed
Chemotherapy in the treatment of Hodgkin's disease. Semin Hematol. 1983 Jan; 20(1):1-24.
View in:
PubMed
Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer. 1982 Dec 15; 50(12):2708-21.
View in:
PubMed
Pulmonary complications of chemotherapy regimens containing bleomycin. AJR Am J Roentgenol. 1982 Sep; 139(3):455-61.
View in:
PubMed
Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma. Cancer Treat Rep. 1982 Jul; 66(7):1585-6.
View in:
PubMed
Occasional notes. The management of early breast cancer. N Engl J Med. 1982 Jun 10; 306(23):1430-2.
View in:
PubMed
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):1015-22.
View in:
PubMed
Histologic progression in non-Hodgkin's lymphoma. Blood. 1982 Feb; 59(2):258-64.
View in:
PubMed
Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. Scan Electron Microsc. 1982; (Pt 1):359-65.
View in:
PubMed
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen. Cancer. 1981 May 15; 47(10):2414-21.
View in:
PubMed
High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg. 1981 Apr; 54(4):455-60.
View in:
PubMed
Breast cancer after Hodgkin's disease in two sisters. Cancer. 1981 Jan 01; 47(1):200-2.
View in:
PubMed
Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Cancer Treat Rep. 1981; 65 Suppl 1:125-9.
View in:
PubMed
Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep. 1981 Jan-Feb; 65(1-2):17-20.
View in:
PubMed
Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue. Cancer Treat Rep. 1981; 65 Suppl 1:67-75.
View in:
PubMed
Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep. 1981; 65 Suppl 1:137-40.
View in:
PubMed
VP-16-213. A phase II trial using a weekly schedule. Cancer Clin Trials. 1981; 4(4):465-7.
View in:
PubMed
Structural and functional effects of adriamycin on cardiac cells in vitro. Cancer Res. 1980 Nov; 40(11):3901-9.
View in:
PubMed
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD). Cancer. 1980 Oct 15; 46(8):1722-6.
View in:
PubMed
Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA). Cancer Treat Rep. 1980 Oct-Nov; 64(10-11):1067-71.
View in:
PubMed
Dose: a critical factor in cancer chemotherapy. Am J Med. 1980 Oct; 69(4):585-94.
View in:
PubMed
cis-Diamminedichloroplatinum(II) therapy for advanced ovarian cancer. Cancer Treat Rep. 1980 Oct-Nov; 64(10-11):1147-8.
View in:
PubMed
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer. 1980 Aug 15; 46(4):669-74.
View in:
PubMed
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med. 1980 May; 92(5):587-95.
View in:
PubMed
Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer. 1980 Apr 01; 45(7):1556-7.
View in:
PubMed
High-dose thymidine infusions in patients with leukemia and lymphoma. Blood. 1980 Apr; 55(4):580-9.
View in:
PubMed
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med. 1980 Mar; 68(3):370-6.
View in:
PubMed
Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med. 1980 Mar; 68(3):356-62.
View in:
PubMed
Cancer of the breast: the past decade (second of two parts). N Engl J Med. 1980 Jan 10; 302(2):78-90.
View in:
PubMed
Cancer of the breast: the past decade (first of two parts). N Engl J Med. 1980 Jan 03; 302(1):17-30.
View in:
PubMed
Treatment of acute nonlymphocytic leukemia with neocarzinostatin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1853-6.
View in:
PubMed
Phase I trial of bruceantin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1929-32.
View in:
PubMed
Chemotherapy of advanced non-Hodgkin's lymphoma. Clin Haematol. 1979 Oct; 8(3):667-84.
View in:
PubMed
Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin. Cancer Treat Rep. 1979 Sep-Oct; 63(9-10):1681-6.
View in:
PubMed
Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore). 1979 Sep; 58(5):377-84.
View in:
PubMed
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog. Cancer Treat Rep. 1979 May; 63(5):919-23.
View in:
PubMed
Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion. Blood. 1979 May; 53(5):1014-7.
View in:
PubMed
Reconstitution or resurrection of normal stem cells in chronic granulocytic leukemia. N Engl J Med. 1979 Feb 15; 300(7):360-1.
View in:
PubMed
High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study. Cancer Treat Rep. 1979 Feb; 63(2):275-9.
View in:
PubMed
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med. 1978 Dec 07; 299(23):1261-6.
View in:
PubMed
Phase I and preliminary phase II study of neocarzinostatin. Cancer Treat Rep. 1978 Dec; 62(12):2019-25.
View in:
PubMed
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Cancer. 1978 Aug; 42(2 Suppl):1001-7.
View in:
PubMed
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Cancer. 1978 Aug; 42(2 Suppl):922-5.
View in:
PubMed
Chemotherapy of the non-Hodgkin's lymphomas. Cancer. 1978 Aug; 42(2 Suppl):932-40.
View in:
PubMed
The staging and treatment of non-Hodgkin's lymphoma. Br J Haematol. 1978 Aug; 39(4):477-82.
View in:
PubMed
Oncologic emergencies. Semin Oncol. 1978 Jun; 5(2):225-7.
View in:
PubMed
Diagnosis and treatment of Hodgkin's disease. Med Times. 1978 Mar; 106(3):30-5.
View in:
PubMed
Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep. 1978 Mar; 62(3):321-5.
View in:
PubMed
Treatment of the non-Hodgkin's lymphomas. Med Times. 1978 Mar; 106(3):37-41.
View in:
PubMed
Treatment of the leukemias. Med Times. 1978 Mar; 106(3):42-5, 49.
View in:
PubMed
A therapeutic trial of maytansine. Cancer Clin Trials. 1978; 1(2):113-7.
View in:
PubMed
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement. Blood. 1977 Dec; 50(6):1039-47.
View in:
PubMed
Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med. 1977 Oct; 63(4):542-7.
View in:
PubMed
Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast. Cancer Treat Rep. 1977 Oct; 61(7):1365-7.
View in:
PubMed
Risk of new cancers in patients with Hodgkin's disease. Cancer. 1977 Oct; 40(4 Suppl):1912-6.
View in:
PubMed
Sequential staging in non-Hodgkin's lymphoma. Cancer Treat Rep. 1977 Sep; 61(6):993-7.
View in:
PubMed
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Cancer Treat Rep. 1977 Sep; 61(6):1153-9.
View in:
PubMed
Basophilic chronic granulocytic leukaemia with hyperhistaminaemia. Br J Haematol. 1977 Jul; 36(3):367-72.
View in:
PubMed
Characteristics of blast crisis in chronic granulocytic leukemia. Blood. 1977 May; 49(5):705-14.
View in:
PubMed
The treatment of chronic granulocytic leukaemia. Clin Haematol. 1977 Feb; 6(1):113-28.
View in:
PubMed
The place of radiation therapy in the treatment of non-Hodgkin's lymphomas. Cancer. 1977 Feb; 39(2 Suppl):843-51.
View in:
PubMed
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer. 1976 Nov; 38(5):1882-6.
View in:
PubMed
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med. 1976 Oct; 85(4):417-22.
View in:
PubMed
Chronic granulocytic leukemia. Med Clin North Am. 1976 Sep; 60(5):1001-18.
View in:
PubMed
Serum ferritin concentration in untreated Hodgkin's disease. Br J Cancer. 1976 Aug; 34(2):162-6.
View in:
PubMed
Extranodal presentation of non-Hodgkin's lymphomas in the testis. Cancer. 1976 Aug; 38(2):1026-35.
View in:
PubMed
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Ann Intern Med. 1976 Aug; 85(2):149-54.
View in:
PubMed
Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood. 1976 Jun; 47(6):1003-9.
View in:
PubMed
Chronic granulocytic leukemia without the Philadelphia chromosome. Am J Clin Pathol. 1976 Apr; 65(4):467-70.
View in:
PubMed
Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med. 1976 Apr; 84(4):389-92.
View in:
PubMed
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. Blood. 1976 Feb; 47(2):211-22.
View in:
PubMed
Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients. Ann Intern Med. 1976 Jan; 84(1):17-21.
View in:
PubMed
Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. Am J Med. 1975 Dec; 59(6):819-28.
View in:
PubMed
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. Natl Cancer Inst Monogr. 1975 Oct; 42:145-8.
View in:
PubMed
High dose intravenous bleomycin in the treatment of advanced lymphomas. Eur J Cancer. 1975 Sep; 11(9):623-6.
View in:
PubMed
Editorial: Combination chemotherapy for breast cancer. Cancer Chemother Rep. 1975 Sep-Oct; 59(5):893-4.
View in:
PubMed
Letter: second malignancies complicating Hodgkin's disease in remission. Lancet. 1975 Jun 07; 1(7919):1294.
View in:
PubMed
Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group IIIa metal salts. Cancer Chemother Rep. 1975 May-Jun; 59(3):599-610.
View in:
PubMed
Second malignancies complicating Hodgkin's disease in remission. Lancet. 1975 Apr 26; 1(7913):947-9.
View in:
PubMed
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med. 1975 Mar; 58(3):322-9.
View in:
PubMed
Results of combination chemotherapy of non-Hodgkin's lymphoma. Br J Cancer Suppl. 1975 Mar; 2:465-73.
View in:
PubMed
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med. 1975 Mar; 58(3):314-21.
View in:
PubMed
Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Br J Cancer Suppl. 1975 Mar; 2:474-80.
View in:
PubMed
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. Cancer. 1975 Feb; 35(2):354-7.
View in:
PubMed
Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. Blood. 1975 Feb; 45(2):197-203.
View in:
PubMed
Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975 Feb 01; 1(7901):248-50.
View in:
PubMed
Letter: Combination chemotherapy for breast cancer. Br Med J. 1975 Jan 04; 1(5948):37.
View in:
PubMed
Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer. 1975 Jan; 35(1):98-110.
View in:
PubMed
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide. Gynecol Oncol. 1974 Dec; 2(4):489-97.
View in:
PubMed
Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. Blood. 1974 Oct; 44(4):483-7.
View in:
PubMed
Procabazine induced oxidative haemolysis: relationship in vivo red cell survival. Br J Haematol. 1974 Aug; 27(4):587-95.
View in:
PubMed
Letter: Leukaemia and lower-motor-neuron disease. Lancet. 1974 Jul 13; 2(7872):107-8.
View in:
PubMed
Mediastinal adenopathy in granulocytic leukemia. Arch Intern Med. 1974 Jul; 134(1):135-8.
View in:
PubMed
Treatment of malignant melanoma with methyl CCNU. Clin Pharmacol Ther. 1974 Jun; 15(6):617-22.
View in:
PubMed
The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med. 1974 Mar; 83(3):489-95.
View in:
PubMed
Evidence for granulocytic incorporation of 67gallium in chronic granulocytic leukemia. J Lab Clin Med. 1974 Mar; 83(3):496-503.
View in:
PubMed
Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J. 1974 Feb 09; 1(5901):218-20.
View in:
PubMed
Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. Blood. 1974 Feb; 43(2):181-9.
View in:
PubMed
Hypercalcemia in malignant lymphoma and leukemia. Ann N Y Acad Sci. 1974; 230:240-6.
View in:
PubMed
Recently recognized complications of cancer chemotherapy. Ann N Y Acad Sci. 1974; 230:481-8.
View in:
PubMed
High-dose intermittent intravenous infusion of procarbazine (NSC-77213). Cancer Chemother Rep. 1973 Sep-Oct; 57(3):361-3.
View in:
PubMed
Maintenance chemotherapy for advanced Hodgkin's disease in remission. Lancet. 1973 Jun 16; 1(7816):1339-43.
View in:
PubMed
Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU). Cancer. 1973 May; 31(5):1164-9.
View in:
PubMed
Intensive chemotherapy for Hodgkin's disease: long-term complications. Natl Cancer Inst Monogr. 1973 May; 36:447-54.
View in:
PubMed
Combination chemotherapy and survival in advanced Hodgkin's disease. Arch Intern Med. 1973 Mar; 131(3):388-90.
View in:
PubMed
Hyperkalaemia, a sequel to chemotherapy of Burkitt's lymphoma. Lancet. 1973 Jan 06; 1(7793):10-4.
View in:
PubMed
Philadelphia-chromosome-positive preleukaemic state. Lancet. 1972 Dec 09; 2(7789):1227-8.
View in:
PubMed
A decade of combination chemotherapy of advanced Hodgkin's disease. Cancer. 1972 Dec; 30(6):1495-504.
View in:
PubMed
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med. 1972 Nov 30; 287(22):1119-22.
View in:
PubMed
Treatment of ovarian carcinoma: possibilities for progress. N Engl J Med. 1972 Oct 26; 287(17):856-62.
View in:
PubMed
Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229). Cancer Chemother Rep. 1972 Oct; 56(5):611-4.
View in:
PubMed
Late recurrence of testicular tumor. N Engl J Med. 1972 Aug 24; 287(8):413.
View in:
PubMed
Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulocytic leukemia. Cancer. 1972 Jul; 30(1):288-93.
View in:
PubMed
Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously. Cancer Chemother Rep. 1972 Jun; 56(3):387-91.
View in:
PubMed
Treatment of the lymphomas. Semin Hematol. 1972 Apr; 9(2):193-209.
View in:
PubMed
Splenectomy for thrombocytopenia in chronic granulocytic leukemia. Cancer. 1972 Mar; 29(3):660-5.
View in:
PubMed
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med. 1972 Feb; 76(2):227-34.
View in:
PubMed
Proceedings: Malignant lymphoma: treatment with combination chemotherapy. Proc Natl Cancer Conf. 1972; 7:379-90.
View in:
PubMed
Proceedings: The chronic leukemias: current therapeutic concepts. Proc Natl Cancer Conf. 1972; 7:351-7.
View in:
PubMed
Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood. 1971 Dec; 38(6):671-9.
View in:
PubMed
Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med. 1971 Nov 18; 285(21):1163-70.
View in:
PubMed
Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU. N Engl J Med. 1971 Aug 26; 285(9):475-9.
View in:
PubMed
Hepatocellular carcinoma with the carcinoid syndrome. Cancer. 1971 May; 27(5):1182-9.
View in:
PubMed
Hypercalcemia in chronic granulocytic leukemia. Cancer. 1971 Apr; 27(4):872-80.
View in:
PubMed
Effect of L-asparaginase on mouse bone marrow, assayed by in vitro culture. Blood. 1970 Sep; 36(3):385-9.
View in:
PubMed
Biocmical and pharmacologic effects of L-asparaginase in man. J Lab Clin Med. 1970 May; 75(5):763-70.
View in:
PubMed
Asparagine biosynthesis in human KB tumor cells: inhibitor studies with asparagine and glutamine antagonists. Cancer Res. 1970 Apr; 30(4):1081-3.
View in:
PubMed
Effects of sulphydryl inhibition on the erythrocyte in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1970 Mar; 18(3):269-77.
View in:
PubMed
Studies of resistance to L-asparaginase in human leukemia. Recent Results Cancer Res. 1970; 33:188-93.
View in:
PubMed
L-asparaginase treatment of acute myeloblastic leukemia. Oncology. 1970; 24(5):349-57.
View in:
PubMed
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med. 1969 Nov 06; 281(19):1028-34.
View in:
PubMed
l-asparaginase resistance in human leukemia--asparagine synthetase. Biochem Pharmacol. 1969 Oct; 18(10):2578-80.
View in:
PubMed
Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy. Am J Ophthalmol. 1969 Sep; 68(3):500-4.
View in:
PubMed
Destructive bone lesions in chronic granulocytic leukemia. Medicine (Baltimore). 1969 Sep; 48(5):401-10.
View in:
PubMed
L-asparaginase and Burkitt's lymphoma. Lancet. 1969 Aug 16; 2(7616):380.
View in:
PubMed
L-asparaginase toxicity. Cancer Res. 1969 Apr; 29(4):974-5.
View in:
PubMed
Asparaginase and leukaemia. Lancet. 1969 Mar 22; 1(7595):626.
View in:
PubMed
Hypoalbuminemic and hypocholesterolemic effect of L-asparaginase (NSC-109,229) treatment in man--a preliminary report. Cancer Chemother Rep. 1969 Feb; 53(1):67-9.
View in:
PubMed
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood. 1968 Nov; 32(5):755-66.
View in:
PubMed
The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity. Cancer Res. 1967 Apr; 27(4):784-8.
View in:
PubMed
Hypoglycorrhachia in meningeal carcinomatosis. Cancer. 1966 May; 19(5):691-4.
View in:
PubMed
Myocardial infarction in one of a pair of twenty-seven year old identical male twins. Am J Med. 1963 May; 34:741-6.
View in:
PubMed